Rockville, Md. (BUSINESS WIRE) - BioReliance Corporation announced today it has established a commercial office in Tokyo, expanding its operations to significantly address the growth opportunities in the Asia Pacific 
markets. BioReliance Corporation is a leading contract services company that provides biologics safety testing, toxicology, viral manufacturing and laboratory animal diagnostic services to the pharmaceutical and biopharmaceutical industries worldwide.
"With an established and growing business already in Japan and other Asian Pacific countries, BioReliance has served this region successfully for many years," said David A. Dodd, President, CEO and Chairman of BioReliance Corporation.
"However, as these markets continue to flourish, we believe that, with a full-time and expanding presence, we can more rapidly serve the needs of our pharmaceutical/biopharmaceutical clients in this region, while increasing new business relationships.""Locating in Tokyo will provide a strategic advantage for BioReliance," said Dave Bellitt, Vice President, Global Commercial Operations ? Biologics. "With the experienced team we are assembling, we will be able to deliver the highest quality, on-time portfolio of biosafety services to the rapidly developing pharmaceutical and biopharmaceutical research industry in this region. Our immediate goal is to complete staffing and pursue new clients aggressively.
Long-term, we are committed to increasing our global leadership position by further expansion and growth in this region."About BioReliance BioReliance Corporation is a leading specialist provider of cost-effective contract services to the pharmaceutical and biopharmaceutical industries, offering more than 1,000 tests or services related to biologics safety testing, in vitro and in vivo toxicology, viral manufacturing, GMP manufacturing, pre-clinical testing and lab animal health diagnostics. Founded in 1947 as Microbiological Associates, BioReliance is headquartered in Rockville, Maryland, and has primary facilities in Rockville, Glasgow, Scotland and Stirling, Scotland, and employs more than 700 people globally.
For more information, visit www.bioreliance.com.
BioReliance Corporation
David Walker, 301-610-2866 Vice President & Chief Financial Officer
OR
Parallax Communications Group
Scott Litherland, 317-638-7898
slitherland@parallaxgroup.net
No comments:
Post a Comment